Alar Pharmaceuticals Inc. (TPEX:6785)
Taiwan · Delayed Price · Currency is TWD 183.50
+3.50 (1.94%)
Aug 12, 2025, 1:30 PM CST
Alar Pharmaceuticals Market Cap
Alar Pharmaceuticals has a market cap or net worth of 12.26 billion as of August 11, 2025. Its market cap has decreased by -12.20% in one year.
Market Cap
12.26B
Enterprise Value
9.90B
Revenue
7.07M
Ranking
n/a
PE Ratio
n/a
Stock Price
183.50
Market Cap Chart
Since October 5, 2020, Alar Pharmaceuticals's market cap has increased from 2.57B to 12.26B, an increase of 377.89%. That is a compound annual growth rate of 38.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2025 | 12.02B | 27.21% |
| Dec 31, 2024 | 9.45B | -20.85% |
| Dec 29, 2023 | 11.94B | 82.17% |
| Dec 30, 2022 | 6.56B | 151.37% |
| Dec 30, 2021 | 2.61B | -6.63% |
| Dec 31, 2020 | 2.79B | 8.89% |
| Oct 5, 2020 | 2.57B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Caliway Biopharmaceuticals | 203.18B |
| PharmaEssentia | 166.30B |
| Bora Pharmaceuticals Co., LTD. | 88.86B |
| Lotus Pharmaceutical | 56.28B |
| Oneness Biotech | 30.90B |
| Polaris Group | 27.31B |
| Center Laboratories | 26.39B |
| Pegavision | 24.38B |